O'Malley; James Paul

Patent Applications and Registrations

Patent applications and USPTO patent grants for O'Malley; James Paul.The latest application filed is for "difluorolactam compositions for ep4-mediated osteo related diseases and conditions".

Company Profile

0.5.7

O'Malley; James Paul - Dunedin NZ
O'Malley; James Paul - Quaker Hill CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods, systems, and compositions for promoting bone growth Grant 10,729,810 - Barrett , et al.	2020-08-04
Difluorolactam Compositions For Ep4-mediated Osteo Related Diseases And Conditions App 20190144435 - Barrett; Stephen Douglas ; et al.	2019-05-16
Difluorolactam Compositions For Ep4-mediated Osteo Related Diseases And Condtions App 20170260173 - Barrett; Stephen Douglas ; et al.	2017-09-14
Difluorolactam compositions for EP.sub.4-mediated osteo related diseases and conditions Grant 9,701,630 - Barrett , et al. July 11, 2	2017-07-11
Lactam compounds as EP.sub.4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions Grant 9,688,627 - Barrett , et al. June 27, 2	2017-06-27
Lactam compounds as EP.sub.4 receptor-selective agonists for use in the treatment of EP.sub.4-mediated diseases and conditions Grant 9,676,712 - Barrett , et al. June 13, 2	2017-06-13
Difluorolactam Compositions For Ep4-mediated Osteo Related Diseases And Conditions App 20160340306 - Barrett; Stephen Douglas ; et al.	2016-11-24
Difluorolactam compositions for EP4-mediated osteo related diseases and conditions Grant 9,440,919 - Barrett , et al. September 13, 2	2016-09-13
Methods, Systems, And Compositions For Promoting Bone Growth App 20160158413 - Barrett; Stephen Douglas ; et al.	2016-06-09
Lactam Compounds As Ep4 Receptor-selective Agonists For Use In The Treatment Of Ep4-mediated Diseases And Conditions App 20160060216 - Barrett; Stephen Douglas ; et al.	2016-03-03
Lactam Compounds As Ep4 Receptor-selective Agonists For Use In The Treatment Of Ep4-mediated Diseases And Conditions App 20160031811 - Barrett; Stephen Douglas ; et al.	2016-02-04
Difluorolactam Compositions For Ep4-mediated Osteo Related Diseases And Conditions App 20150174099 - Barrett; Stephen Douglas ; et al.	2015-06-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.